术中分子成像与二次窗吲哚菁绿在颅内立体定向针吸活检中确认强化组织:病例系列
该病例系列报道5例疑似胶质瘤或肿瘤复发患者接受二次窗吲哚菁绿(SWIG)引导的立体定向活检,术前约24小时给予最多5 mg/kg ICG,术中在标准可见光和近红外成像下检查标本。共获得10份标本,3份无荧光且病理无肿瘤,7份有荧光中6份含肿瘤、1份含坏死;荧光特征与初步和最终诊断高度一致。SWIG可快速术中确认病变脑组织,可能提高活检效率。
要点
- SWIG引导立体定向活检在5例患者中可行,术前约24小时给予最多5 mg/kg ICG。
- 10份标本中7份荧光阳性,其中6份含肿瘤、1份含坏死;3份无荧光且病理无肿瘤。
- 荧光特征与初步和最终病理诊断高度一致。
核心结论
- SWIG通过类似钆增强的机制渗透肿瘤性或炎性脑组织,可快速术中确认病变脑组织。
- SWIG引导立体定向活检可通过增强对获取目标组织的信心来提高手术效率。
研究设计与样本
- 病例系列,5例疑似胶质瘤或肿瘤复发患者接受SWIG引导的立体定向活检。
- 术前约24小时给予最多5 mg/kg ICG,术中采用无框架导航靶向疑似肿瘤区域。
- 标本在标准可见光和近红外成像平台下检查,并与冰冻和最终肿瘤病理对照。
主要发现
- 共获得10份活检标本,3份无荧光且初步和最终病理均无肿瘤,包括一份取自最终靶点近端、无钆增强的标本。
- 7份标本有荧光,其中6份含肿瘤、1份含坏死。
- 一例放射性治疗效应患者也观察到荧光。
- 荧光特征与初步和最终诊断高度一致。
关键数值与推荐
- ICG剂量:最多5 mg/kg。
- 给药时机:术前约24小时。
- 标本数:共10份;荧光阳性7份,其中肿瘤6份、坏死1份;无荧光3份且无肿瘤。
临床怎么用
- SWIG可在术中快速提供病理脑组织的确认。
- SWIG引导立体定向活检可能通过增强对获取目标组织的信心来提高手术效率。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Stereotactic needle biopsy provides a minimally invasive option for the diagnosis of intracranial lesions but is limited by inconclusive diagnoses on frozen pathology. For rapid pathology, 5-aminovelunic acid and sodium fluorescein have previously demonstrated potential as diagnostic adjuvants. Stereotactic biopsy with near-infrared (NIR) fluorophores has not been reported. We identified 5 representative cases using NIR fluorescent dye indocyanine green (ICG) administered in a high dose, delayed manner. METHODS: Five patients underwent second window indocyanine green (SWIG)-guided stereotactic biopsy for diagnosis of suspected glioma or tumor recurrence. Up to 5 mg/kg ICG was administered approximately 24 hours prior to surgery. Biopsies were conducted in the standard fashion, targeting regions of suspected tumor using intraoperative frameless navigation. Samples were examined intraoperatively under standard visible light and for fluorescence using conventional NIR imaging platforms. Findings were correlated with frozen and final tumor pathology for all cases. RESULTS: A total of 10 biopsy specimens were obtained. Three did not fluoresce and did not demonstrate tumor on preliminary or final pathology, including a non-gadolinium-enhancing sample taken proximal to the final target. The remaining 7 fluoresced, of which 6 contained tumor and 1 contained necrosis. Fluorescence was also noted in a patient with radiation treatment effect. Overall fluorescence characteristics were highly concordant with preliminary and final diagnoses. CONCLUSIONS: SWIG provides rapid intraoperative confirmation of pathologic brain tissue by permeating neoplastic or inflammatory brain tissue via a mechanism similar to that of gadolinium enhancement. SWIG-guided stereotactic biopsy can improve surgical efficiency by enhancing confidence in acquisition of target tissue.
引用
- Li C, Sullivan PZ, Cho S, et al. Intraoperative Molecular Imaging with Second Window Indocyanine Green Facilitates Confirmation of Contrast-Enhancing Tissue During Intracranial Stereotactic Needle Biopsy: A Case Series. World Neurosurg. 2019. PMID: 30885869. doi:10.1016/j.wneu.2019.02.231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。